Y020-2321 Screening compound: 2-(1H-1,3-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol

Y020-2321 Screening compound: 2-(1H-1,3-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol
Y020-2321 Screening compound: 2-(1H-1,3-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-2321
2-(1H-1,3-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-2321

Molecular Formula

C14H14N4O (C14 H14 N4 O)

Compound Name

2-(1H-1,3-benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol

IUPAC name

2-(1H-13-benzodiazol-2-yl)-4567-tetrahydro-2H-indazol-3-ol

SMILES

Oc1c(CCCC2)c2nn1-c1nc(cccc2)c2[nH]1

InChI

InChI=1S/C14H14N4O/c19-13-9-5-1-2-6-10(9)17-18(13)14-15-11-7-3-4-8-12(11)16-14/h3-4,7-8,19H,1-2,5-6H2,(H,15,16)

InChI Key

QJICXFFAJZYBEJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08132377

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

254.29

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

1.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.221

Distribution Coefficient, logD

2.221

Water Solubility, LogSw

-1.97

Polar Surface Area

49.151

Acid Dissociation Constant (pKa)

7.46

Base Dissociation Constant (pKb)

8.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.57

Y020-2321 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Cardiovascular
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y020-2321 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-2321?
Check Price and Availability of Y020-2321, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-2321 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-2321
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-2321
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-2321 available by request